The weight-loss properties of GLP-1 drugs, including Ozempic and Wegovy, have dominated headlines. But could they also cut alcohol consumption? And what would this mean for beverage manufacturers? The ...

Drinking alcohol while using Mounjaro is generally considered safe, but it may increase the likelihood of the drug’s side effects. Alcohol can also make blood sugar levels harder to manage for people ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Once-weekly subcutaneous injections of semaglutide (Ozempic, Novo Nordisk) reduced alcohol cravings and consumption in adults with alcohol use disorder (AUD), findings from a small phase 2 ...

: Dr. Palmer: You look fantastic. Christine: Thank you, I feel it. Narrator: Christine lost 150 pounds through diet and sheer will power. Michael lost 140 pounds when he combined exercise and meal ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research presented at the European Congress on Obesity (ECO ...

An ingredient in the prescription diabetes drug Mounjaro was found to reduce alcohol intake in rodents, according to a recent study. In the study, published in early January in the medical journal ...

Several research studies, either in progress or in planning stages, are testing whether GLP-1 agonists can help people who have symptoms of an alcohol use disorder reduce drinking. The goal of the ...

Addiction is a chronic relapsing condition with high morbidity and mortality. Despite existing psychosocial and pharmacological interventions, available medications are limited and often ineffective ...

A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity. That’s what scientists at a leading research institute have found. In a ...